Ping Capital Management’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-12,000
Closed -$317K – 97
2026
Q1
$317K Buy
+12,000
New +$351K 0.09% 74
2025
Q4
– Sell
-15,000
Closed -$417K – 81
2025
Q3
$417K Sell
15,000
-1,000
-6% -$25.3K 0.14% 52
2025
Q2
$390K Sell
16,000
-1,000
-6% -$21.9K 0.09% 60
2025
Q1
$353K Buy
17,000
+2,000
+13% +$50.2K 0.13% 68
2024
Q4
$353K Buy
15,000
+1,000
+7% +$24.6K 0.09% 68
2024
Q3
$358K Buy
14,000
+3,900
+39% +$99.3K 0.1% 66
2024
Q2
$237K Buy
+10,100
New +$255K 0.07% 66

Other funds holding ARKG

Ping Capital Management's ARKG Position: Q2 2026 in Review

Ping Capital Management sold out of ARK Genomic Revolution ETF (ARKG) in Q2 2026, closing a stake of 12,000 shares — an estimated $317K sold.

Ping Capital Management first reported a position in ARKG in Q2 2024 and held it in 7 quarters. The position peaked at $417K in Q3 2025. 278 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

  • Ping Capital Management reported no remaining ARK Genomic Revolution ETF position as of Q2 2026 after selling out during the quarter.
  • Ping Capital Management sold 12,000 ARK Genomic Revolution ETF shares in Q2 2026, an estimated $317K.
  • Ping Capital Management first reported a position in ARK Genomic Revolution ETF in Q2 2024 and held it in 7 quarters.
  • Ping Capital Management's ARK Genomic Revolution ETF position peaked at $417K in Q3 2025.
  • 278 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on Ping Capital Management's 13F filing for Q2 2026, filed 20 Jul 2026.